NCT00444665已完成4 期
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 750
- 试验地点
- 2
- 主要终点
- Ocular Surface Disease Symptoms
研究概览
简要总结
Examine the safety, tolerability and efficacy of travoprost benzalkonium chloride (BAK) free ophthalmic solution compared to either latanoprost or bimatoprost monotherapy.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults with a clinical diagnosis of ocular hypertension, or primary open-angle, pigment dispersion or exfoliation glaucoma in at least one eye (study eye)
排除标准
- 未提供
结局指标
主要结局
Ocular Surface Disease Symptoms
次要结局
- Intraocular pressure
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Ocular Surface Disease and IOP Monitoring With Travoprost Without ConservativesGlaucomaOcular Surface DiseaseDrugs GlaucomaNCT05319470Democritus University of Thrace25
已完成
4 期
Safety and Efficacy of Changing to DuoTrav in Patients Uncontrolled on TimololGlaucomaNCT01336569Alcon Research50
已完成
4 期
Success of Transitioning Uncontrolled Glaucoma Patients From Prior Mono or Adjunctive Therapy to DuoTravGlaucomaNCT00519753Alcon Research522
终止
4 期
Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma PatientsGlaucoma, Angle-ClosureNCT01151904Allergan17
已完成
2 期
Efficacy and Safety of Bromfenac Ophthalmic SolutionCataract SurgeryNCT00585975Bausch & Lomb Incorporated568